P. Gobert

2.4k total citations
17 papers, 111 citations indexed

About

P. Gobert is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, P. Gobert has authored 17 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in P. Gobert's work include Renal Diseases and Glomerulopathies (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Pneumonia and Respiratory Infections (2 papers). P. Gobert is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Pneumonia and Respiratory Infections (2 papers). P. Gobert collaborates with scholars based in France, United States and Belgium. P. Gobert's co-authors include D. Fleury, Philippe Vanhille, Stéphane Burtey, O. Aumaître, Pascal Godmer, X. Kyndt, O. Decaux, D Droz, J.-J. Pessey and Loı̈c Guillevin and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and American Journal of Nephrology.

In The Last Decade

P. Gobert

16 papers receiving 106 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Gobert France 7 56 38 25 25 24 17 111
Stavros Chrysidis Denmark 8 63 1.1× 12 0.3× 20 0.8× 32 1.3× 112 4.7× 17 167
Lino Cirami Italy 6 24 0.4× 112 2.9× 16 0.6× 21 0.8× 22 0.9× 11 154
Lisa Lima United States 7 19 0.3× 21 0.6× 21 0.8× 7 0.3× 9 0.4× 12 101
Tarun Kumar Saha Bangladesh 3 105 1.9× 235 6.2× 22 0.9× 13 0.5× 11 0.5× 4 253
Thibaud Chazal France 6 82 1.5× 11 0.3× 11 0.4× 21 0.8× 34 1.4× 14 128
E. Fonseca-Aizpuru Spain 7 28 0.5× 13 0.3× 9 0.4× 20 0.8× 77 3.2× 9 130
Xing Changying China 6 14 0.3× 63 1.7× 12 0.5× 33 1.3× 6 0.3× 14 116
Christine B. Sethna United States 6 19 0.3× 62 1.6× 15 0.6× 12 0.5× 4 0.2× 12 106
Stéphane Bally France 4 35 0.6× 77 2.0× 10 0.4× 45 1.8× 7 0.3× 11 100
Marie‐Pierre Lavocat France 5 18 0.3× 146 3.8× 40 1.6× 18 0.7× 22 0.9× 9 190

Countries citing papers authored by P. Gobert

Since Specialization
Citations

This map shows the geographic impact of P. Gobert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Gobert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Gobert more than expected).

Fields of papers citing papers by P. Gobert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Gobert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Gobert. The network helps show where P. Gobert may publish in the future.

Co-authorship network of co-authors of P. Gobert

This figure shows the co-authorship network connecting the top 25 collaborators of P. Gobert. A scholar is included among the top collaborators of P. Gobert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Gobert. P. Gobert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bobot, Mickaël, P. Gobert, Éric Magnant, et al.. (2021). Kidney biopsy in very elderly patients: indications, therapeutic impact and complications. BMC Nephrology. 22(1). 362–362. 2 indexed citations
2.
Daniel, Laurent, M. Devos, K. Mazodier, et al.. (2018). Néphropathies au cours de la leucémie lymphoïde chronique : à propos d’une étude monocentrique de 10 cas. La Revue de Médecine Interne. 39(8). 612–617. 4 indexed citations
3.
Jamme, Matthieu, Quentin Raimbourg, Dominique Chauveau, et al.. (2017). Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome. PLoS ONE. 12(5). e0177894–e0177894. 14 indexed citations
4.
Terrier, Benjamin, Christian Pagnoux, A. Karras, et al.. (2013). OP0213 Rituximab Versus Azathioprine for Maintenance in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis (MAINRITSAN): Follow Up at 34 Months. Annals of the Rheumatic Diseases. 72. A124–A124. 8 indexed citations
5.
Guillevin, Loı̈c, Christian Pagnoux, Alexandre Karras, et al.. (2013). Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. A prospective study in 117 patients. La Presse Médicale. 42(4). 679–679. 19 indexed citations
6.
Terrier, Benjamin, Christian Pagnoux, Alexandre Karras, et al.. (2013). Rituximab versus azathioprine for maintenance in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (MAINRITSAN): Follow-up at 34 months. La Presse Médicale. 42(4). 778–779. 6 indexed citations
7.
Bataille, Stanislas, N. Jourde, Laurent Daniel, et al.. (2012). Comparative Safety and Efficiency of Five Percutaneous Kidney Biopsy Approaches of Native Kidneys: A Multicenter Study. American Journal of Nephrology. 35(5). 387–393. 19 indexed citations
8.
9.
Lh, Nöel, X. Kyndt, D Droz, et al.. (2005). Thrombotic microangiopathy in adult Still's disease. Scandinavian Journal of Rheumatology. 34(5). 399–403. 14 indexed citations
10.
Gobert, P., et al.. (2002). [Surgical treatment of osteoid osteoma of the spine using intraoperative scintigraphy].. PubMed. 68(3). 301–5. 4 indexed citations
11.
Cattoën, C., V. Lemaı̂tre, L. Bouillet, et al.. (1994). Infections à Staphylococcus aureus chez l'hémodialysé et portage nasal. Utilisation de la mupirocine. Médecine et Maladies Infectieuses. 24. 668–673. 1 indexed citations
12.
Philip‐Joet, F., et al.. (1994). Cefpodoxime-proxétil (CPD) 5 jours versus céfuroxime-axétil (CXM) 10 jours dans le traitement des suppurations bronchiques aiguës du sujet âgé. Médecine et Maladies Infectieuses. 24. 681–685. 3 indexed citations
13.
Pessey, J.-J., et al.. (1994). Efficacité et tolérance du cefpodoxime-proxétil (CPD) versus céfuroxime-axétil (CXM) dans le traitement des sinusites aiguës de l'adulte. Médecine et Maladies Infectieuses. 24. 686–692. 5 indexed citations
14.
Hazzan, Marc, Frank Bridoux, A Vérier, P. Gobert, & Philippe Vanhille. (1991). [Urologic manifestations in Wegener's disease].. PubMed. 142(4). 319–20. 2 indexed citations
15.
Fleury, D., et al.. (1990). [Renal cholesterol embolism. Apropos of 13 cases].. PubMed. 19(22). 1040–4. 2 indexed citations
16.
Vanhille, Philippe, et al.. (1986). [Rapidly progressing glomerulonephritis with mesangial IgA deposits in sarcoidosis].. PubMed. 7(5). 207–9. 7 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stavros Chrysidis Breakdown of academic impact, for papers by Lino Cirami Breakdown of academic impact, for papers by Lisa Lima Breakdown of academic impact, for papers by Tarun Kumar Saha Breakdown of academic impact, for papers by Thibaud Chazal Breakdown of academic impact, for papers by E. Fonseca-Aizpuru Breakdown of academic impact, for papers by Xing Changying Breakdown of academic impact, for papers by Christine B. Sethna Breakdown of academic impact, for papers by Stéphane Bally Breakdown of academic impact, for papers by Marie‐Pierre Lavocat
Rankless by CCL
2026